- Home
- URG vs CMPS Comparison
URG vs CMPS Comparison
Compare URG & CMPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- URG
- CMPS
- Stock Information
- Founded
- URG 2004
- CMPS 2020
- Country
- URG United States
- CMPS United Kingdom
- Employees
- URG N/A
- CMPS N/A
- Industry
- URG Precious Metals
- CMPS Biotechnology: Pharmaceutical Preparations
- Sector
- URG Basic Materials
- CMPS Health Care
- Exchange
- URG Nasdaq
- CMPS Nasdaq
- Market Cap
- URG 419.5M
- CMPS 364.9M
- IPO Year
- URG N/A
- CMPS 2020
- Fundamental
- Price
- URG $1.48
- CMPS $5.14
- Analyst Decision
- URG Strong Buy
- CMPS Strong Buy
- Analyst Count
- URG 3
- CMPS 7
- Target Price
- URG $2.63
- CMPS $17.00
- AVG Volume (30 Days)
- URG 5.8M
- CMPS 1.8M
- Earning Date
- URG 11-05-2025
- CMPS 10-30-2025
- Dividend Yield
- URG N/A
- CMPS N/A
- EPS Growth
- URG N/A
- CMPS N/A
- EPS
- URG N/A
- CMPS N/A
- Revenue
- URG $39,488,000.00
- CMPS N/A
- Revenue This Year
- URG N/A
- CMPS N/A
- Revenue Next Year
- URG $232.02
- CMPS N/A
- P/E Ratio
- URG N/A
- CMPS N/A
- Revenue Growth
- URG 149.20
- CMPS N/A
- 52 Week Low
- URG $0.55
- CMPS $2.25
- 52 Week High
- URG $1.62
- CMPS $7.53
- Technical
- Relative Strength Index (RSI)
- URG 62.21
- CMPS 66.04
- Support Level
- URG $1.33
- CMPS $4.40
- Resistance Level
- URG $1.62
- CMPS $5.27
- Average True Range (ATR)
- URG 0.09
- CMPS 0.32
- MACD
- URG 0.02
- CMPS 0.05
- Stochastic Oscillator
- URG 68.48
- CMPS 90.00
About URG Ur Energy Inc (Canada)
Ur-Energy Inc is engaged in uranium mining and recovery operations, with activities including the acquisition, exploration, development, and production of uranium mineral resources located in Wyoming. The company owns and operates the Lost Creek in-situ recovery uranium facility in south-central Wyoming, Lost Creek received an amendment to its license allowing the expansion of mining activities within the existing Lost Creek Project and the adjacent LC East Project.
About CMPS COMPASS Pathways Plc American Depository Shares
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.